Hyaluronic Acid

A naturally occurring substance found in connective tissue, skin, and joint fluid throughout the body. It holds moisture, lubricates joints, and adds volume to skin. Used in many forms: injectable fillers for facial volume, joint injections for arthritis, topical serums for skin hydration, and oral supplements. Different sizes (molecular weights) have different effects. People use it for wrinkles, joint pain, and skin hydration.

Dosage

Intra-articular: 20-60 mg per injection. Topical: 0.1-2% serum. Oral: 120-240 mg daily

Dosages shown are for research reference only. Always consult a qualified healthcare provider.

Half-Life

Intra-articular: 24-72 hours (1-3 days) | Dermal filler: 4320-12960 hours (6-18 months) depending on cross-linking

Half-Life Calculator →

Administration

Intra-articular injection, dermal injection, topical, or oral

Shop Research-Grade Peptides

99%+ purity · US-based · third-party lab tested

Browse →

Getting Started — Here's What You'll Need

Effects

Joint Lubrication

Restores synovial fluid viscosity and shock-absorbing properties in arthritic joints.

Skin Hydration

Each molecule binds up to 1,000x its weight in water for dermal volume and hydration.

Wound Healing

CD44 receptor signaling stimulates fibroblast collagen synthesis.

Mechanism of Action

Hyaluronic acid (HA) is a non-sulfated glycosaminoglycan composed of repeating disaccharide units of D-glucuronic acid and N-acetyl-D-glucosamine, linked by alternating beta-1,4 and beta-1,3 glycosidic bonds. Its extraordinary water-binding capacity — a single HA molecule can bind up to 1,000 times its weight in water — is due to the highly hydrophilic carboxyl groups on the glucuronic acid residues, which create a massive hydration shell around the polymer chain.

In joints, high-molecular-weight HA (>1 million Daltons) is the primary determinant of synovial fluid viscosity and elasticity (viscoelasticity). Healthy synovial fluid contains 2-4 mg/mL of HA at molecular weights of 6-7 million Daltons, creating a non-Newtonian fluid that becomes more viscous under slow shear (cushioning at rest) and more elastic under rapid shear (shock absorption during movement). Viscosupplementation with injected HA restores these rheological properties in osteoarthritic joints where endogenous HA has degraded. Beyond simple lubrication, injected HA also reduces inflammatory mediators by binding to CD44 and RHAMM receptors on synovial cells, suppressing IL-1β and TNF-α production.

In skin, HA occupies the extracellular matrix of the dermis, providing volume, hydration, and structural support. It signals through the CD44 receptor (the primary HA receptor) on dermal fibroblasts, activating downstream pathways that stimulate collagen synthesis, fibroblast proliferation, and tissue remodeling. Different molecular weights of HA have different biological effects: high-molecular-weight HA (>500 kDa) is anti-inflammatory and provides structural volume; low-molecular-weight HA fragments (oligosaccharides) are pro-angiogenic and stimulate immune responses, which is useful for wound healing but must be considered in dermal filler applications. Cross-linked HA (used in dermal fillers like Juvederm and Restylane) is chemically modified with BDDE or other cross-linkers to resist enzymatic degradation by hyaluronidases, extending residence time from days to 6-18 months.

Regulatory Status

FDA approved for multiple indications. Dermal fillers (Juvederm, Restylane). Viscosupplementation (Synvisc, Hyalgan). Topical/oral as cosmetics/supplements.

Risks & Safety

Common

swelling, bruising, pain at injection site, temporary joint stiffness with joint injections.

Serious

if accidentally injected into a blood vessel, can block blood flow and cause tissue death or blindness around the eyes; lump formation, infection.

Rare

severe allergic reaction, delayed allergic reactions, bluish discoloration under the skin.

Compare Hyaluronic Acid With

Research Papers

30
Effects of antibiotics encapsulated in hyaluronic acid hydrogels on different osteogenic cells and bacteria.

Published: February 10, 2026

AI Summary

Antibiotics loaded into hyaluronic acid hydrogels did not harm bone cells at clinical doses and effectively inhibited Staphylococcus aureus. Cefuroxime was released faster than vancomycin, suggesting the hydrogel could be used to treat implant-related infections in orthopedics.

Biometallic peptide-drug conjugates in photo-crosslinkable hydrogels enable combined photothermal-chemotherapy against breast cancer.

Published: February 9, 2026

AI Summary

Peptide–drug conjugates with gold nanoparticles in a hyaluronic acid hydrogel achieved strong tumor suppression in breast cancer when combined with heat and chemotherapy. The system released drug in response to tumor acidity and could be activated with light for localized treatment.

Heparin-Modified Aligned Collagen Scaffolds Enhance In Vitro Myogenesis.

Published: February 24, 2026

AI Summary

Collagen scaffolds with heparin promoted muscle cell growth and differentiation better than those with hyaluronic acid or chondroitin sulfate. Heparin also trapped more IGF-1, a key growth factor, highlighting how scaffold chemistry can be tuned for muscle tissue engineering.

Shedding of endothelial glycocalyx and increased vascular permeability in patients with obstructive jaundice: A prospective observational study.

Published: February 5, 2026

AI Summary

Patients with obstructive jaundice had higher blood levels of shed glycocalyx components—hyaluronic acid, chondroitin sulfate, and syndecan-1—and increased vascular permeability. Protecting the glycocalyx may offer a way to improve outcomes around surgery in these patients.

HA/CD44-SS31 Mitochondrial Targeting of Manganese Oxide Nanozymes for Ischemia-Reperfusion-Induced Acute Kidney Injury Therapy.

Published: February 5, 2026

AI Summary

Manganese oxide nanoparticles coated with hyaluronic acid and the mitochondria-targeting peptide SS31 reduced kidney damage and improved survival in mice with ischemia-reperfusion injury. Delivering antioxidants to mitochondria may help break the cycle of oxidative stress and inflammation in acute kidney injury.

The 7S Domain of Type IV Collagen as a Noninvasive Surrogate of Portal Hypertension.

Published: February 4, 2026

AI Summary

The 7S domain of type IV collagen was evaluated as a noninvasive marker for portal hypertension and high-risk varices in liver disease. The work aims to identify a reliable blood test alternative to invasive pressure measurement.

Hyaluronic acid-ethylenediamine-cinnamic acid attenuates IBS-D via regulating 5-hydroxytryptamine signaling pathway, intestinal barrier and gut microbiota.

Published: February 2, 2026

AI Summary

A hyaluronic acid–cinnamic acid conjugate improved diarrhea, gut sensitivity, and barrier function in a mouse model of IBS-D by modulating serotonin signaling and gut bacteria. The compound delivered more cinnamic acid to the colon than free cinnamic acid alone, suggesting a potential new treatment for IBS-D.

Inhibition of CD154:CD11b interactions using a novel nanotherapeutic improves allograft survival.

Published: February 1, 2026

AI Summary

Nanoparticles carrying a peptide that blocks CD154–CD11b binding, when combined with CTLA-4Ig, prolonged skin graft survival in mice and reduced donor-reactive T cells. Some mice treated for 100 days developed lasting tolerance without further immunosuppression.

Soluble Antigen Arrays Alter the Response of Epitope-Specific Diabetogenic T Cells.

Published: February 3, 2026

AI Summary

Soluble antigen arrays built on hyaluronic acid and displaying type 1 diabetes autoantigens engaged human T cell clones with high specificity. The platform could support targeted immunotherapy for type 1 diabetes without broad immunosuppression.

Prolonged Release of IL-10 From Enzyme-Mediated Poly-l-(Tyrosine-co-Phenylalanine) Nanocrystals Enhances Stability and Modulates Inflammatory Responses.

Published: March 13, 2026

AI Summary

IL-10 was encapsulated in peptide nanocrystals and released slowly over about a month, protecting the cytokine from degradation. When embedded in gelatin–hyaluronic acid or PHBV matrices, the system reduced inflammation in cell culture and could support treatment of inflammatory skin conditions.

A multifunctional and ROS response CO-gas delivery platform for spinal cord regeneration.

Published: April 4, 2026

AI Summary

A carbon monoxide–releasing platform using hyaluronic acid to target microglia reduced inflammation, eased hypoxia, and protected neurons in a spinal cord injury model. The system releases CO in response to reactive oxygen species, offering a potential therapy for neurotrauma.

In vitro assessment of antibacterial and biocompatibility properties of a poly-ε-lysine and hyaluronic acid contact-killing coating to prevent prosthetic joint infection.

Published: January 29, 2026

AI Summary

A poly-lysine and hyaluronic acid coating on implant materials killed bacteria on contact and reduced bacterial adhesion by up to 5 logs without harming bone cells. The coating could help prevent prosthetic joint infections without relying on antibiotics.

Oral delivery of liraglutide using CPP/hyaluronic acid-modified mesoporous silica nanoparticles: A virus-inspired strategy for intestinal absorption.

Published: May 13, 2026

AI Summary

Liraglutide loaded into silica nanoparticles coated with a cell-penetrating peptide and hyaluronic acid was absorbed orally in diabetic rats, lowering blood sugar and body weight comparably to injected liraglutide. The approach could enable non-injectable delivery of peptide drugs.

Medical Fabrics with Non-Antibiotic, Supramolecular Antimicrobial Coatings: A Preventive Approach to Combat Biofilm Formation and Bacterial Dissemination.

Published: January 27, 2026

AI Summary

Medical fabric coated with polyarginine and hyaluronic acid reduced bacterial load by at least 6 logs and prevented biofilm formation in wound infection models, including MRSA. The antibiotic-free coating could help prevent wound infections and combat resistant bacteria.

Engineered GO-Based Hydrogels for Controlled Hyaluronic Acid Release in Knee Osteoarthritis Treatment.

Published: January 5, 2026

AI Summary

Hydrogels combining peptide gelators with graphene oxide functionalized with hyaluronic acid enabled controlled release of HA for osteoarthritis treatment. The nanocomposites aim to support cartilage repair and reduce inflammation while mimicking the mechanical environment of joint tissue.

Hyaluronan of Different Molecular Weights Exerts Distinct Therapeutic Effects on Bleomycin-Induced Acute Respiratory Distress Syndrome.

Published: January 5, 2026

AI Summary

Different molecular weights of hyaluronan had distinct effects in a rat model of acute respiratory distress syndrome, with mixed-weight HA providing the best improvement in lung structure and function. The results suggest HA-based strategies could be tailored for ARDS treatment.

Serum soluble ASGR1 concentration is elevated in patients with metabolic dysfunction-associated steatotic liver disease and is associated with adiponectin.

Published: January 26, 2026

AI Summary

Serum soluble ASGR1 was higher in patients with fatty liver disease and linked to adiponectin. The work explores whether this receptor could serve as a biomarker or target in metabolic liver disease.

Enzymatically-responsive hyaluronan-glucose hydrogel supports MSC survival and preserves paracrine function under glucose deprivation.

Published: February 19, 2026

AI Summary

A hyaluronic acid–glucose hydrogel that releases glucose when enzymes cleave it helped stem cells survive and function in low-glucose conditions. The stem cell secretome from this hydrogel improved chondrocyte growth and reduced inflammation, suggesting a potential treatment for osteoarthritis.

Hyaluronic acid-coated amphiphilic polyaspartic acid-drug conjugates self-assembling nanoparticles for tumor specific fluorescence imaging and chemotherapy.

Published: February 20, 2026

AI Summary

Hyaluronic acid–coated nanoparticles carrying doxorubicin delivered drug selectively to tumor cells, where glutathione triggered release and fluorescence. In mice, the system reduced tumor volume fivefold compared to saline and twofold compared to free drug, with minimal toxicity.

Soluble Antigen Array Displaying Proinsulin(F25D) Selectively Targets Anti-insulin B Cells without Hormonal Effects.

Published: February 1, 2026

AI Summary

A modified proinsulin antigen on a hyaluronic acid backbone targeted anti-insulin B cells without affecting blood sugar. The approach could support antigen-specific immunotherapy for type 1 diabetes while avoiding hormonal side effects.

In Situ Ca2+-Reinforced Full-Active Hydrogels for the Treatment of Rheumatoid Arthritis by Modulating the NF-κB and NLRP3 Pathways.

Published: February 3, 2026

AI Summary

An injectable hydrogel that crosslinks with calcium in the joint reduced inflammation, scavenged reactive oxygen species, and improved arthritis scores in rats, outperforming dexamethasone. The natural components—hyaluronic acid, alginate, and paeoniflorin—support its potential for clinical use in rheumatoid arthritis.

Injectable hydrogel microspheres delivering cartilage-targeted LGR5-engineered exosomes for osteoarthritis therapy.

Published: February 16, 2026

AI Summary

Exosomes engineered to target cartilage and loaded into hyaluronic acid microspheres promoted cartilage repair and slowed osteoarthritis progression in mice. The system retained exosomes in the joint longer and improved cartilage scores, suggesting a promising strategy for OA treatment.

Targeting Hyaluronic Acid Increases Brain Retention of Intraventricular Dosed Antibodies in Mice.

Published: February 1, 2026

AI Summary

Antibodies fused to an hyaluronic acid–binding domain stayed in the brain longer after injection into the ventricles, improving exposure compared to unmodified antibodies. The approach could help develop more effective antibody therapies for brain and spinal cord disorders.

Fabrication of Dissolvable Microneedle Patches Loaded with α-Lactalbumin Nanomicelles for Transdermal Capsaicin Delivery and Adipose Tissue Reduction.

Published: December 29, 2025

AI Summary

Dissolvable microneedles made from hyaluronic acid and polyvinyl alcohol delivered capsaicin-loaded nanomicelles through the skin, reducing fat mass and promoting fat browning in obese mice. The protocol offers a minimally invasive way to deliver hydrophobic compounds for obesity management.

Cell surface engineering with a pseudofibrotic ECM reprograms the antifibrotic activity of mesenchymal stromal cells.

Published: January 15, 2026

AI Summary

Coating mesenchymal stem cells with a hyaluronic acid–based matrix that mimics fibrotic tissue boosted their ability to break down collagen and reduce scarring in a heart attack model. The approach could improve cell-based therapies for fibrotic diseases.

Gynostemma pentaphyllum Hydrodistillate and Damulin B Prevent UVB-Induced Photoaging In Vitro and In Vivo via ROS Suppression and Restoration of MAPK/AP-1 and TGF-β/Smad Signaling.

Published: January 17, 2026

AI Summary

Gynostemma pentaphyllum extract and its bioactive compound Damulin B reduced UV-induced wrinkles, preserved collagen and hyaluronic acid, and improved skin hydration in mice. The effects were linked to lower oxidative stress and restored signaling pathways that maintain skin structure.

A multifunctional hyaluronic acid modified gelatin methacryloyl hydrogel for infected wound healing: synergistic photothermal antibacterial and immune-microenvironment remodeling.

Published: February 12, 2026

AI Summary

A gelatin–hyaluronic acid hydrogel loaded with polydopamine-coated cerium dioxide killed bacteria under near-infrared light and shifted macrophages toward a healing phenotype. In infected wounds, the combined treatment achieved over 95% healing by day 15.

Egyptian National Consensus on Dermocosmetic Ingredient Selection Across Common Dermatology Scenarios: A RAND/UCLA Appropriateness Study.

Published: January 14, 2026

AI Summary

Egyptian experts reached consensus on which dermocosmetic ingredients to use in common skin scenarios for Fitzpatrick skin types III–V. The recommendations provide guidance for populations often underrepresented in existing guidelines.

Targeting NF-kappa B/proinflammatory cytokines/ TGF-β/ TIMP-1 pathway by crocin enhances recovery from hepatic fibrosis in rats.

Published: January 13, 2026

AI Summary

Crocin reduced liver fibrosis in rats by targeting inflammatory and fibrotic pathways, including NF-kappaB and TGF-beta. The work explores whether this plant compound could support recovery from liver scarring.

Multiscale insights into fibroblast growth factor 23 adsorption on polyelectrolyte layers: From molecular properties to biointerfaces.

Published: February 11, 2026

AI Summary

FGF23 bound to hyaluronic acid, chitosan, and other charged polymers with different strengths, and desorbed more easily from negatively charged surfaces. The findings inform design of carriers and materials for FGF23-related therapies.

Frequently Asked Questions

What is Hyaluronic Acid?

A naturally occurring substance found in connective tissue, skin, and joint fluid throughout the body. It holds moisture, lubricates joints, and adds volume to skin. Used in many forms: injectable fillers for facial volume, joint injections for arthritis, topical serums for skin hydration, and oral supplements. Different sizes (molecular weights) have different effects. People use it for wrinkles, joint pain, and skin hydration.

What is Hyaluronic Acid used for?

A naturally occurring substance found in connective tissue, skin, and joint fluid throughout the body. It holds moisture, lubricates joints, and adds volume to skin. Used in many forms: injectable fillers for facial volume, joint injections for arthritis, topical serums for skin hydration, and oral supplements. Different sizes (molecular weights) have different effects. People use it for wrinkles, joint pain, and skin hydration.

What is the dosage for Hyaluronic Acid?

Intra-articular: 20-60 mg per injection, series of 3-5 weekly injections. Dermal filler: varies by area and product, administered by trained practitioners. Topical: 0.1-2% serums once or twice daily. Oral: 120-240 mg once daily.

What are the side effects of Hyaluronic Acid?

Common: swelling, bruising, pain at injection site, temporary joint stiffness with joint injections. Serious: if accidentally injected into a blood vessel, can block blood flow and cause tissue death or blindness around the eyes; lump formation, infection. Rare: severe allergic reaction, delayed allergic reactions, bluish discoloration under the skin.

How does Hyaluronic Acid work?

Hyaluronic acid (HA) is a non-sulfated glycosaminoglycan composed of repeating disaccharide units of D-glucuronic acid and N-acetyl-D-glucosamine, linked by alternating beta-1,4 and beta-1,3 glycosidic bonds. Its extraordinary water-binding capacity — a single HA molecule can bind up to 1,000 times its weight in water — is due to the highly hydrophilic carboxyl groups on the glucuronic acid residues, which create a massive hydration shell around the polymer chain. In joints, high-molecular-weight HA (>1 million Daltons) is the primary determinant of synovial fluid viscosity and elasticity (viscoelasticity). Healthy synovial fluid contains 2-4 mg/mL of HA at molecular weights of 6-7 million Daltons, creating a non-Newtonian fluid that becomes more viscous under slow shear (cushioning at rest) and more elastic under rapid shear (shock absorption during movement). Viscosupplementation with injected HA restores these rheological properties in osteoarthritic joints where endogenous HA has degraded. Beyond simple lubrication, injected HA also reduces inflammatory mediators by binding to CD44 and RHAMM receptors on synovial cells, suppressing IL-1β and TNF-α production. In skin, HA occupies the extracellular matrix of the dermis, providing volume, hydration, and structural support. It signals through the CD44 receptor (the primary HA receptor) on dermal fibroblasts, activating downstream pathways that stimulate collagen synthesis, fibroblast proliferation, and tissue remodeling. Different molecular weights of HA have different biological effects: high-molecular-weight HA (>500 kDa) is anti-inflammatory and provides structural volume; low-molecular-weight HA fragments (oligosaccharides) are pro-angiogenic and stimulate immune responses, which is useful for wound healing but must be considered in dermal filler applications. Cross-linked HA (used in dermal fillers like Juvederm and Restylane) is chemically modified with BDDE or other cross-linkers to resist enzymatic degradation by hyaluronidases, extending residence time from days to 6-18 months.

How is Hyaluronic Acid administered?

Hyaluronic Acid is administered via intra-articular injection, dermal injection, topical, or oral.

What is the half-life of Hyaluronic Acid?

The half-life of Hyaluronic Acid is Intra-articular: 24-72 hours (1-3 days) | Dermal filler: 4320-12960 hours (6-18 months) depending on cross-linking.

Is Hyaluronic Acid legal?

FDA approved for multiple indications. Dermal fillers (Juvederm, Restylane). Viscosupplementation (Synvisc, Hyalgan). Topical/oral as cosmetics/supplements.

Related Peptides

Ara-290

A peptide derived from EPO (the hormone that boosts red blood cells) but engineered to keep only the tissue-protective effects — it doesn't increase red blood cells at all. It activates the body's repair receptors to protect tissues and regenerate nerves. Particularly promising for nerve damage and tissue injury from poor blood flow. People use it for diabetic nerve damage and similar conditions.

Healing

Botulinum Toxin

A toxin produced by bacteria — the most potent biological toxin known, yet one of the most widely used cosmetic and medical treatments globally. In carefully controlled doses, it temporarily relaxes targeted muscles by blocking the signal that tells muscles to contract. Approved for cosmetic wrinkle reduction and many medical conditions including chronic migraine, excessive sweating, and neck muscle spasms. People use it for forehead lines, crow's feet, frown lines, and various medical conditions.

Beauty

BPC-157

A healing compound made from a protein found in stomach fluid. It's the most studied peptide for tissue repair, with research showing it helps heal tendons, ligaments, muscles, the gut, and other organs. It's stable enough to survive stomach acid, so you can take it either by injection under the skin or by mouth.

HealingBodybuilding

BPC-157 + TB-500

A two-in-one product that pairs BPC-157 and TB-500 to target different healing pathways. BPC-157 focuses on gut, tendon, and ligament repair by supporting blood vessel growth and nitric oxide signaling, while TB-500 helps cells move to injury sites for body-wide tissue repair. The most popular peptide combination for healing and recovery.

HealingBodybuilding